For over a decade, Ascendia Pharmaceutical Solutions has been at the forefront of lipid nanotechnology, transforming some of the toughest drug delivery challenges into innovative solutions. Guided by our commitment to "making the impossible possible," Ascendia has pioneered advancements in emulsion-based and lipid nanoparticle formulations. Through proprietary technologies such as LipidSol™, EmulSol®, NanoSol®, and AmorSol®, we have cemented our position as industry leaders.
Our journey began with a vision to tackle the challenges of poorly soluble drug molecules. Founded by Dr. Jim Huang over 12 years ago, Ascendia was built on the principle that advanced nanotechnology could unlock new possibilities for drug formulation. Today, our platform technologies cater to a wide range of therapeutic needs, from oral and injectable formulations to topical applications.
Ascendia's proprietary solutions have become synonymous with lipid nanotechnology:
These cutting-edge technologies are tailored to meet the unique challenges of our clients, combining safety, efficacy, and scalability in every solution.
Drug development comes with significant hurdles, particularly when working with poorly water-soluble molecules or high-melting-point compounds. One of the most common challenges is achieving high drug loading without compromising stability. With proprietary excipients, state-of-the-art microfluidic manufacturing, and a holistic approach to formulation design, Ascendia excels in solving these problems.
Our approach ensures:
What sets Ascendia apart is the breadth of our expertise and the integration of all critical capabilities under one roof. Unlike many competitors, we provide comprehensive solutions in-house, including analytical support, stability studies, and microbial testing. This streamlined approach saves our clients time and ensures consistency across all phases of development.
Whether it’s encapsulating nucleic acids for vaccines, developing long-acting injectables, or creating nanosuspensions for oral delivery, our team has the expertise and tools to deliver results.
At Ascendia, we offer flexible partnership models tailored to client needs. From fee-for-service agreements to co-development opportunities with shared intellectual property, we work collaboratively to bring groundbreaking formulations to market.
Our clients turn to us because they trust our ability to deliver where others cannot. This trust stems from our extensive experience and our relentless focus on innovation.
Simply put, Ascendia makes the complex simple and the impossible possible. Whether it's solving high drug-loading challenges or developing patient-centric formulations, we deliver best-in-class solutions that meet regulatory standards and exceed client expectations.
When it comes to emulsions and lipid nanoparticles, think of Ascendia as your partner in innovation. We don’t just deliver formulations—we create solutions that make a difference.